BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37980402)

  • 1. Inhibition of PDGFRβ alleviates endothelial cell apoptotic injury caused by DRP-1 overexpression and mitochondria fusion failure after mitophagy.
    An X; Ma X; Liu H; Song J; Wei T; Zhang R; Zhan X; Li H; Zhou J
    Cell Death Dis; 2023 Nov; 14(11):756. PubMed ID: 37980402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Platelet miR-223 Induction in Kawasaki Disease Leads to Severe Coronary Artery Pathology Through a miR-223/PDGFRβ Vascular Smooth Muscle Cell Axis.
    Zhang Y; Wang Y; Zhang L; Xia L; Zheng M; Zeng Z; Liu Y; Yarovinsky T; Ostriker AC; Fan X; Weng K; Su M; Huang P; Martin KA; Hwa J; Tang WH
    Circ Res; 2020 Sep; 127(7):855-873. PubMed ID: 32597702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin alleviates vascular endothelial cell damage by regulating an autophagy-apoptosis axis in Kawasaki disease.
    Zheng Y; Huang S; Zhang J; Hou J; Wu F; Wang W; Han X; Gui Y
    Cell Prolif; 2022 Jun; 55(6):e13251. PubMed ID: 35582751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease.
    Yasukawa K; Terai M; Shulman ST; Toyozaki T; Yajima S; Kohno Y; Rowley AH
    Circulation; 2002 Feb; 105(6):766-9. PubMed ID: 11839635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crucial role of NLRP3 inflammasome in a murine model of Kawasaki disease.
    Anzai F; Watanabe S; Kimura H; Kamata R; Karasawa T; Komada T; Nakamura J; Nagi-Miura N; Ohno N; Takeishi Y; Takahashi M
    J Mol Cell Cardiol; 2020 Jan; 138():185-196. PubMed ID: 31836541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excess vascular endothelial growth factor-A disrupts pericyte recruitment during blood vessel formation.
    Darden J; Payne LB; Zhao H; Chappell JC
    Angiogenesis; 2019 Feb; 22(1):167-183. PubMed ID: 30238211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROGRESSION OF VASCULAR FUNCTION AND BLOOD PRESSURE IN A MOUSE MODEL OF KAWASAKI DISEASE.
    DelVechio M; Alves JV; Saiyid AZ; Singh S; Galley J; Awata WMC; Costa RM; Bruder-Nascimento A; Bruder-Nascimento T
    Shock; 2023 Jan; 59(1):74-81. PubMed ID: 36703278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins Show Anti-Atherosclerotic Effects by Improving Endothelial Cell Function in a Kawasaki Disease-like Vasculitis Mouse Model.
    Motoji Y; Fukazawa R; Matsui R; Abe Y; Uehara I; Watanabe M; Hashimoto Y; Miyagi Y; Nagi-Miura N; Tanaka N; Ishii Y
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived microRNA-223 attenuates TNF-α induced monocytes adhesion to arterial endothelium by targeting ICAM-1 in Kawasaki disease.
    Guo M; Fan S; Chen Q; Jia C; Qiu M; Bu Y; Tang WH; Zhang Y
    Front Immunol; 2022; 13():922868. PubMed ID: 35983051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIGIRR-caspase-8 signaling mediates endothelial apoptosis in Kawasaki disease.
    Wen Z; Xia Y; Zhang Y; He Y; Niu C; Wu R; Zhang C; Jia C; Rong X; Chu M
    Ital J Pediatr; 2023 Jan; 49(1):2. PubMed ID: 36600293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-receptor type, proline-rich protein tyrosine kinase 2 (Pyk2) is a possible therapeutic target for Kawasaki disease.
    Suzuki C; Nakamura A; Miura N; Fukai K; Ohno N; Yahata T; Okamoto-Hamaoka A; Fujii M; Yoshioka A; Kuchitsu Y; Ikeda K; Hamaoka K
    Clin Immunol; 2017 Jun; 179():17-24. PubMed ID: 28167306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpressed Neuropilin-1 in Endothelial Cells Promotes Endothelial Permeability through Interaction with ANGPTL4 and VEGF in Kawasaki Disease.
    Huang J; Zhang S
    Mediators Inflamm; 2021; 2021():9914071. PubMed ID: 34434074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-197-3p mediates damage to human coronary artery endothelial cells via targeting TIMP3 in Kawasaki disease.
    Liu C; Yang D; Wang H; Hu S; Xie X; Zhang L; Jia H; Qi Q
    Mol Cell Biochem; 2021 Dec; 476(12):4245-4263. PubMed ID: 34351574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymic stromal lymphopoietin induces platelet mitophagy and promotes thrombosis in Kawasaki disease.
    Fu L; MacKeigan DT; Gong Q; Che D; Xu Y; Pi L; Sun C; Yu H; Chen K; Zhou H; Jiang Z; Wang Z; Zhang L; Cerenzia EG; Ni H; Gu X
    Br J Haematol; 2023 Mar; 200(6):776-791. PubMed ID: 36341698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic Target of Rapamycin Inhibition Prevents Coronary Artery Remodeling in a Murine Model of Kawasaki Disease.
    Stock AT; Parsons S; D'Silva DB; Hansen JA; Sharma VJ; James F; Starkey G; D'Costa R; Gordon CL; Wicks IP
    Arthritis Rheumatol; 2023 Feb; 75(2):305-317. PubMed ID: 36057112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective roles of liraglutide on Kawasaki disease via AMPK/mTOR/NF-κB pathway.
    Ding Y; Peng Y; Wu H; Huang Y; Sheng K; Li C; Chu M; Ji W; Guo X
    Int Immunopharmacol; 2023 Apr; 117():110028. PubMed ID: 36934674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro.
    Pfister C; Pfrommer H; Tatagiba MS; Roser F
    Br J Cancer; 2012 Nov; 107(10):1702-13. PubMed ID: 23047550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-37b alleviates endothelial cell apoptosis and inflammation in Kawasaki disease through IL-1R8 pathway.
    Jia C; Zhuge Y; Zhang S; Ni C; Wang L; Wu R; Niu C; Wen Z; Rong X; Qiu H; Chu M
    Cell Death Dis; 2021 Jun; 12(6):575. PubMed ID: 34083516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Roles of Xijiao Dihuang Tang on Coronary Artery Injury in Kawasaki Disease.
    Zhang J; Zhuge Y; Rong X; Ni C; Niu C; Wen Z; Lin H; Chu M; Jia C
    Cardiovasc Drugs Ther; 2023 Apr; 37(2):257-270. PubMed ID: 34665368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine protects Kawasaki disease-induced human coronary artery endothelial cells dysfunction by inhibiting of oxidative and endoplasmic reticulum stress.
    Xu M; Qi Q; Men L; Wang S; Li M; Xiao M; Chen X; Wang S; Wang G; Jia H; Liu C
    Vascul Pharmacol; 2020 Apr; 127():106660. PubMed ID: 32070767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.